Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1996-02-20
1999-07-06
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
424 851, 514 8, 514 12, 514 21, 530351, A61K 4505, C07K 500
Patent
active
059194448
ABSTRACT:
A method for treating acute or chronic pancreatitis comprising administering an effective amount of an Interleukin-1 (IL-1) block to antagonize IL-1 production, and in one embodiment by inhibiting IL-1 production at the source, or a pharmaceutically acceptable salt thereof to a person who has pancreatitis. One such IL-1 block is an Interleukin-1 converting enzyme (ICE) antagonist.
REFERENCES:
patent: 4959217 (1990-09-01), Sanders et al.
patent: 5167616 (1992-12-01), Haak et al.
patent: 5169383 (1992-12-01), Gyory et al.
patent: 5225182 (1993-07-01), Sharma
patent: 5508262 (1996-04-01), Norman, Jr.
Aiura et al., "Interleukin-1 receptor antagonist prevents Staphylococcus epidermidis-induced hypotension . . . " Infection and Immunity, pp. 3342-3350 (1993).
Bamba et al., "Serum levels of interleukin-1 beta and interleukin-6 in patients with chronic pancreatitis" J. Gastroenterology, 29(3):314-19, (1994).
Cioffi et al., "Leukocyte responses to injury" Arch Surg, 128:1260-1267 (1993).
Coticchia et al., "Peritoneal fluid in human acute pancreatitis blocks hepatic mitochondrial respiration" Surgery, 100(5):850-855 (1986).
Dinarello et al., "Anticytokine strategies in treatment of systemic inflammatory response syndrome" JAMA, 269:1829-1834 (1993).
Dolan et al., "Biphasic tumor necrosis factor release in experimental acute pancreatitis" Gut, 35:A575, 1994 (Abstract).
Driscoll, "The Preclinical New Drug Research Program of the National Cancer Institute (1984)" Cancer Treatment Reports, 68:63-76.
Fischer et al., "A comparison between the effects of interleukin-1 administration and sublethal endotoxemia in primates" Am J. Physiol, 261:R442, (1991).
Formela et al., "Demonstration of tumor necrosis factor in pancreatic acinar cells by in situ hybridisation in a model . . . " Gut, 35:A575, 1994 (Abstract).
Granowitz et al., "Effect of interleukin-1 (IL-1)blockade on cytokine synthesis: I. IL-1 receptor antagonist . . . " Blood, 79:2356-2363, (1992b).
Grewal et al., "Anti-TNF therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis . . . " Am. J. Surg., 171:274-280 (1996) plus abstract.
Gross et al., "Inflammatory mediators and cytokines-new aspects of pathophysiology and assessment of severity of acute pancreatitits?" Hepato-Gastroenterol, 40:522-529, (1993).
Guice, et al., "Neutrophil-dependent, oxygen-radical mediated lung associated with acute pancreatitis" Ann Surg, 210: 740-747 (1989).
Imrie and Whyte, "A prospective study of acute pancreatitis" Br J Surg, 62:490-494 (1975).
Jacobs et al., "Acute pancreatitis: analysis of factors influencing survival" Ann Surg, 185:43-51, (1977).
Kelly et al, m "Microvasculature of the pancreas, liver, and kidney in caerulein induced pancreatitis" Arch Surg, 128:292-295 (1993).
Kuida et al., "Altered cytokine export and apoptosis in mice deficient in interleukin-1.beta. converting enzyme" Science, (1995).
Kusske et al., "Interleukin 10 (IL-10) prevents death in lethal necrotizing pancreatitis (AP) in mice" Society of University Surgeons 57th Annual Meeting, Feb., 1996, p. 40 (abstract).
Lowry, "Cytokine mediators of immunity and inflammation" Arch Surg, 128:1235-1241, (1993).
McKay et al., "Systemic complications in acute pancreatitis are associated with increased monocyte cytokine release" Gut, 35:A575, (1994) (Abstract).
Mohler, "The use of soluble TNF receptors as inhibitors of inflammation" Proceedings of Regulation of Cytokine Activity for Therapeutic
Norman et al., Rapid elevation of systemic cytokines during acute pancreatitis and their origination within the pancreas Surg Forum XLV:191-194 (1994a).
Norman and Franz, "Acute phase cytokines during experimental acute
Norman et al., "Decreased severity of experimental acute pancreatitis by pre or post treatment . . . " 28th Annual Meeting, Pancreas Club, Inc. (New Orleans, LA) May (1994d). (Abstract 1994, p. 23 and reference).
Norman et al., "Interleukin-1 receptor antagonist decreases severity of acute pancreatitis" Surgery, 117:648-655 (1995a).
Norman et al., "Decreased mortality of severe acute pancreatitis after proximal cytokine blockade" Annals of Surgery, 221:625-634 (1995b).
Okusawa et al., "Interleukin-1 induces a shock-like state in rabbits" Synergism with tumor necrosis factor . . . J Clin Invest, 81:1162 (1988).
Oppenheim et al., "Clinical applications of cytokines; role in pathogenesis diagnosis and therapy" Oxford University Press, NY, NY (1993) (related pages only).
Pappas et al., "Pancreatitis-associated ascitic fluid: effect on oxygen consumption of liver cells" Soc Exp Biol Med., 169:438-444 (1982).
Physicians' Desk Reference.RTM.: pp. 1654-1658 (1994).
Ranson and Spencer, "Role of peritoneal lavage in severe acute pancreatitis" Ann Surg, 187:565-573, (1978).
Rodgers and Carey, "Peritoneal lavage in experimental pancreatitis in dogs" Amer J. Surg, 111:792-794 (1966).
Saluja et al., "In vivo rat pancreatic acinar cell function during supramaximal stimulation with caerulien" Amer Physiological Society, G702-710 (1985).
Spillenaar Bilgen et al., "Attempts to reduce post-transplant pancreatitis in rats and dogs with the somatostatin analogue . . . " Transplant Proceed, 21:2829-2830 (1989).
Steer, "How and where does acute pancreatitis?" Arch Surg, 127:1350-1353 (1992).
Steinberg and Tenner, "Acute pancreatitis" N Eng J Med, 330:1198-1220 (1994).
Stone and Fabian, "Peritoneal dialysis in treatment of acute alcoholic pancreatitis" Surg Gynecol Obstet, 150:878-882 (1980).
Van Ooijen et al., "Significance of thromboxane A.sub.2 and prostaglandin in acute necrotizing pancreatitis in rats" Digestive Disease and Sciences, 35:1078-1084 (1990).
Waage and Espevik, "Interleukin-1 potentiates the lethal effect of tumor necrosis factor/cachectic in mice" J Exp Med, 167:1987 (1988).
Wakabayashi et al., "A specific receptor antagonist for interleukin-1 prevents E. coli induced shock in rabbits" FASEB, 5:338 (1991).
Zhu et al., "A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat" Pancreas, 6:609-613 (1991).
Elford et al., J. Pharm. (Jun. 1995) vol. 115 pp. 601-606.
Miller et al, J. Immun vol. 154, No. 3 (Feb. 1, 1995) pp. 1331-1338.
Goodman & Gilman's "The Pharmacological Basis of Therapeutics" 6th Ed. (MacMillan Pub. 1980) pp. 1738-1740.
Celsa Bennett
Tsang Cecilia J.
University of South Florida
LandOfFree
Method for decreasing severity of acute and chronic pancreatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for decreasing severity of acute and chronic pancreatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for decreasing severity of acute and chronic pancreatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-897200